Psoriasis: open trials in South Korea

8 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-11-03
NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Pusan National University Hospital, Busan · Kyung Hee University Hospital, Dongdaemun-gu · Chosun University Hospital, Donggu · Seoul National University Hospital, Jongno-gu · Seoul National University Bundang Hospital, Seongnam-si · Cha Bundang Medical Center, Cha University, Seongnam-si, Gyeonggi-do · Yonsei University Health System, Severance Hospital, Seoul · Konkuk University Medical Center, Seoul
Registry updated 2026-10-28
NCT04772079
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Local Institution - 0047, Seoul · Local Institution - 0048, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul
Registry updated 2026-10-26
NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Trial Treatment · Phase 3 · Takeda
Kyung Hee University Hospital, Seoul · Asan Medical Center, Seoul · SMG-SNU Boramae Medical Center, Seoul · Ajou University Hospital | Clinical Trial Center, Suwon · The Catholic University of Korea, Suwon
Registry updated 2026-10-14
NCT07243782
Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
Research · Novartis Pharmaceuticals
Novartis Investigative Site, Seoul
Registry updated 2026-03-05
NCT07011979
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Research · Seoul National University Hospital
Seoul National University Hospital, Seoul
Registry updated 2025-06-10
NCT06258668
Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
Research · Bristol-Myers Squibb
Local Institution - 0001, Seoul · Novotech Laboratory Korea Co., Ltd., Seoul
Registry updated 2024-11-06
NCT01965132
Korean College of Rheumatology Biologics and Targeted Therapy Registry
Research · Seoul National University Hospital
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul
Registry updated 2024-04-26

All Psoriasis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error